Concepts (83)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Elapid Venoms | 8 | 2020 | 16 | 1.960 |
Why?
|
| Complement C3 | 5 | 2020 | 16 | 1.290 |
Why?
|
| Directed Molecular Evolution | 1 | 2024 | 6 | 0.870 |
Why?
|
| Integrases | 1 | 2024 | 28 | 0.860 |
Why?
|
| Transgenes | 1 | 2024 | 65 | 0.850 |
Why?
|
| Recombinant Fusion Proteins | 6 | 2020 | 296 | 0.790 |
Why?
|
| Complement C3-C5 Convertases | 4 | 2020 | 4 | 0.780 |
Why?
|
| Complement Factor B | 1 | 2020 | 1 | 0.660 |
Why?
|
| Mutagenesis, Insertional | 2 | 2025 | 39 | 0.450 |
Why?
|
| Transposases | 1 | 2025 | 9 | 0.240 |
Why?
|
| Genome, Human | 1 | 2025 | 144 | 0.220 |
Why?
|
| Attachment Sites, Microbiological | 1 | 2024 | 2 | 0.220 |
Why?
|
| Bacteriophages | 1 | 2024 | 44 | 0.210 |
Why?
|
| Amino Acid Sequence | 2 | 2019 | 1180 | 0.200 |
Why?
|
| Complement Factor H | 2 | 2020 | 5 | 0.180 |
Why?
|
| Mutation | 1 | 2024 | 1177 | 0.150 |
Why?
|
| Sequence Analysis, Protein | 1 | 2019 | 52 | 0.150 |
Why?
|
| Structure-Activity Relationship | 2 | 2019 | 506 | 0.150 |
Why?
|
| Antibody Formation | 1 | 2018 | 76 | 0.140 |
Why?
|
| Humans | 9 | 2025 | 43102 | 0.140 |
Why?
|
| Antibodies, Neutralizing | 1 | 2018 | 127 | 0.130 |
Why?
|
| Immunomagnetic Separation | 1 | 2016 | 4 | 0.130 |
Why?
|
| Spores, Bacterial | 1 | 2016 | 9 | 0.130 |
Why?
|
| Bacillus anthracis | 1 | 2016 | 33 | 0.130 |
Why?
|
| Immunoglobulin Isotypes | 1 | 2015 | 16 | 0.120 |
Why?
|
| Immunoglobulins | 1 | 2015 | 39 | 0.120 |
Why?
|
| Turtles | 1 | 2015 | 31 | 0.120 |
Why?
|
| Animals | 8 | 2020 | 16992 | 0.110 |
Why?
|
| Biosensing Techniques | 1 | 2016 | 136 | 0.110 |
Why?
|
| Complement Factor D | 2 | 2012 | 2 | 0.110 |
Why?
|
| Complement Activation | 2 | 2012 | 14 | 0.110 |
Why?
|
| Plasmids | 2 | 2012 | 244 | 0.100 |
Why?
|
| Molecular Sequence Data | 2 | 2015 | 1542 | 0.100 |
Why?
|
| Elapidae | 1 | 2012 | 2 | 0.090 |
Why?
|
| Enzyme Stability | 1 | 2012 | 34 | 0.090 |
Why?
|
| Amino Acid Substitution | 1 | 2012 | 135 | 0.090 |
Why?
|
| Mutation, Missense | 1 | 2012 | 91 | 0.090 |
Why?
|
| Protein Structure, Tertiary | 1 | 2012 | 423 | 0.090 |
Why?
|
| Complement System Proteins | 2 | 2008 | 25 | 0.080 |
Why?
|
| Cloning, Molecular | 2 | 2009 | 314 | 0.070 |
Why?
|
| Recombinant Proteins | 2 | 2004 | 518 | 0.060 |
Why?
|
| DNA Transposable Elements | 1 | 2025 | 55 | 0.060 |
Why?
|
| Binding Sites | 1 | 2025 | 671 | 0.050 |
Why?
|
| DNA | 1 | 2025 | 592 | 0.050 |
Why?
|
| DNA-Binding Proteins | 1 | 2025 | 561 | 0.050 |
Why?
|
| Drosophila melanogaster | 2 | 2018 | 193 | 0.040 |
Why?
|
| Cricetulus | 1 | 2018 | 82 | 0.030 |
Why?
|
| CHO Cells | 1 | 2018 | 123 | 0.030 |
Why?
|
| Cricetinae | 1 | 2018 | 241 | 0.030 |
Why?
|
| Bioterrorism | 1 | 2016 | 20 | 0.030 |
Why?
|
| Electrodes | 1 | 2016 | 59 | 0.030 |
Why?
|
| Immunoassay | 1 | 2016 | 74 | 0.030 |
Why?
|
| Immunoglobulin Light Chains | 1 | 2015 | 5 | 0.030 |
Why?
|
| Receptors, Fc | 1 | 2015 | 7 | 0.030 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2015 | 12 | 0.030 |
Why?
|
| Antigens | 1 | 2015 | 59 | 0.030 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2015 | 57 | 0.030 |
Why?
|
| Antibodies | 1 | 2015 | 144 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2015 | 160 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2015 | 174 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2018 | 1621 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2015 | 306 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2018 | 1869 | 0.020 |
Why?
|
| Mice | 2 | 2018 | 6644 | 0.020 |
Why?
|
| Fibrinogen | 1 | 2009 | 24 | 0.020 |
Why?
|
| Sheep | 1 | 2009 | 77 | 0.020 |
Why?
|
| Hemolysis | 1 | 2009 | 60 | 0.020 |
Why?
|
| Arthritis, Experimental | 1 | 2008 | 8 | 0.020 |
Why?
|
| Protein Engineering | 1 | 2008 | 49 | 0.020 |
Why?
|
| Protein Structure, Secondary | 1 | 2008 | 182 | 0.020 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2008 | 51 | 0.020 |
Why?
|
| Protein Binding | 1 | 2009 | 1082 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2009 | 876 | 0.010 |
Why?
|
| Tunicamycin | 1 | 2004 | 21 | 0.010 |
Why?
|
| Glycosylation | 1 | 2004 | 113 | 0.010 |
Why?
|
| Magnesium | 1 | 2004 | 94 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2004 | 196 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2004 | 165 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2004 | 185 | 0.010 |
Why?
|
| Protein Conformation | 1 | 2004 | 416 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2004 | 460 | 0.010 |
Why?
|
| Cell Line | 1 | 2004 | 1410 | 0.010 |
Why?
|
| Time Factors | 1 | 2004 | 1857 | 0.010 |
Why?
|